Susquehanna International Group
PTX

Susquehanna International Group’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Susquehanna International Group’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-21,300
Closed -$21K – 10693
2018
Q3 		$21K Sell
21,300
-400
-2% -$669 ﹤0.01% 8995
2018
Q2 		$53K Buy
+21,700
New +$53.1K ﹤0.01% 9262
2018
Q1 		– Sell
-17,700
Closed -$42K – 10869
2017
Q4 		$42K Sell
17,700
-15,400
-47% -$42.6K ﹤0.01% 8957
2017
Q3 		$104K Buy
+33,100
New +$106K ﹤0.01% 8349
2016
Q3 		– Sell
-1,390
Closed -$6K – 9543
2016
Q2 		$6K Sell
1,390
-180
-11% -$1.18K ﹤0.01% 8440
2016
Q1 		$16K Sell
1,570
-740
-32% -$14.7K ﹤0.01% 8845
2015
Q4 		$68K Sell
2,310
-250
-10% -$7.56K ﹤0.01% 9029
2015
Q3 		$81K Sell
2,560
-870
-25% -$41.6K ﹤0.01% 9231
2015
Q2 		$203K Buy
3,430
+1,680
+96% +$118K ﹤0.01% 9271
2015
Q1 		$187K Sell
1,750
-2,560
-59% -$244K ﹤0.01% 8675
2014
Q4 		$405K Sell
4,310
-14,150
-77% -$1.35M ﹤0.01% 7628
2014
Q3 		$1.42M Sell
18,460
-5,800
-24% -$457K ﹤0.01% 5246
2014
Q2 		$2.18M Buy
+24,260
New +$1.49M ﹤0.01% 4506

Other funds holding PTX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
MFGP
Marshall Financial Group (Pennsylvania) Doylestown, Pennsylvania $364M AUM 12.86% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group's PTX Position: Q2 2018 in Review

Susquehanna International Group sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q2 2018, closing a stake of 15,124 shares — an estimated $37K sold.

Susquehanna International Group first reported a position in PTX in Q2 2014 and held it in 10 quarters. The position peaked at $854K in Q2 2014. 29 funds tracked by Wall St. Rank hold PTX as of Q2 2018.

  • Susquehanna International Group reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q2 2018 after selling out during the quarter.
  • Susquehanna International Group sold 15,124 Pernix Therapeutics Holdings, Inc. shares in Q2 2018, an estimated $37K.
  • Susquehanna International Group first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2014 and held it in 10 quarters.
  • Susquehanna International Group's Pernix Therapeutics Holdings, Inc. position peaked at $854K in Q2 2014.
  • 29 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q2 2018.

Based on Susquehanna International Group's 13F filing for Q2 2018, filed 14 Aug 2018.